Clinical Trials Logo

Hemolysis clinical trials

View clinical trials related to Hemolysis.

Filter by:
  • Temporarily not available  
  • Page 1

NCT ID: NCT05221619 Temporarily not available - Clinical trials for Warm Autoimmune Hemolytic Anemia

Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)

Start date: n/a
Phase:
Study type: Expanded Access

The purpose of this post-trial access (PTA) program is to provide nipocalimab for the treatment of participants with Warm Autoimmune Hemolytic Anemia (wAIHA) who are experiencing clinical benefit after completing 28-weeks open-label extension in MOM-M281-006 (NCT04119050) study.